Sugar‐Based Arylsulfonamide Carboxylates as Selective and Water‐Soluble Matrix Metalloproteinase‐12 Inhibitors

Matrix metalloproteinase‐12 (MMP‐12) can be considered an attractive target to study selective inhibitors useful in the development of new therapies for lung and cardiovascular diseases. In this study, a new series of arylsulfonamide carboxylates, with increased hydrophilicity resulting from conjugation with a β‐N‐acetyl‐d‐glucosamine moiety, were designed and synthesized as MMP‐12 selective inhibitors. Their inhibitory activity was evaluated on human MMPs by using the fluorimetric assay, and a crystallographic analysis was performed to characterize their binding mode. Among these glycoconjugates, a nanomolar MMP‐12 inhibitor with improved water solubility, compound 3 [(R)‐2‐(N‐(2‐(3‐(2‐acetamido‐2‐deoxy‐β‐d‐glucopyranosyl)thioureido)ethyl)biphenyl‐4‐ylsulfonamido)‐3‐methylbutanoic acid], was identified.

[1]  H. V. Van Wart,et al.  Hydrolysis of a Broad Spectrum of Extracellular Matrix Proteins by Human Macrophage Elastase* , 1997, The Journal of Biological Chemistry.

[2]  P. Williams,et al.  Hepititol conformations revisited: C,O versus O,O parallel 1,3-interactions , 1986 .

[3]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[4]  C. Luchinat,et al.  A High‐Affinity Carbohydrate‐Containing Inhibitor of Matrix Metalloproteinases , 2006, ChemMedChem.

[5]  Ying Yu,et al.  Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease. , 2010, Journal of medicinal chemistry.

[6]  Cristina Nativi,et al.  Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs). , 2010, European journal of medicinal chemistry.

[7]  D. Macmillan,et al.  Native N-glycopeptide thioester synthesis through N→S acyl transfer , 2011, Bioorganic & medicinal chemistry letters.

[8]  T. Butters,et al.  Amphiphilic 1-deoxynojirimycin derivatives through click strategies for chemical chaperoning in N370S Gaucher cells. , 2011, The Journal of organic chemistry.

[9]  V. K. Srivastava.  A facile synthesis of 2-methyl-(3,4,6-tri-O-acetyl-1,2-dideoxy-α-d-glucopyrano)-[2,1-e]-2-oxazoline , 1982 .

[10]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[11]  Günther Richter,et al.  Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[13]  Denis Duran,et al.  PROXIMA 2A – A New Fully Tunable Micro-focus Beamline for Macromolecular Crystallography , 2013 .

[14]  C. Warren,et al.  A new procedure for the preparation of oligosaccharide oxazolines. , 1986, Carbohydrate research.

[15]  Alexei Vagin,et al.  Molecular replacement with MOLREP. , 2010, Acta crystallographica. Section D, Biological crystallography.

[16]  S. Sabesan,et al.  Synthesis of glycosyl phosphates and azides , 1992 .

[17]  Y. Sasaguri,et al.  Matrix metalloproteinase 12 accelerates the initiation of atherosclerosis and stimulates the progression of fatty streaks to fibrous plaques in transgenic rabbits. , 2008, The American journal of pathology.

[18]  Armando Rossello,et al.  Crystallization of bi-functional ligand protein complexes. , 2013, Journal of structural biology.

[19]  Arwin J. Brouwer,et al.  High‐Yielding Microwave‐Assisted Synthesis of Triazole‐Linked Glycodendrimers by Copper‐Catalyzed [3+2] Cycloaddition , 2005 .

[20]  Dimitris Georgiadis,et al.  A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity , 2014, Nature Medicine.

[21]  H. Magnussen,et al.  Safety and tolerability of an oral MMP-9 and -12 inhibitor, AZD1236, in patients with moderate-to-severe COPD: a randomised controlled 6-week trial. , 2011, Pulmonary pharmacology & therapeutics.

[22]  K. Frei,et al.  Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme. , 2004, Analytical biochemistry.

[23]  A. Reynolds,et al.  Design, synthesis, and structure-affinity relationships of regioisomeric N-benzyl alkyl ether piperazine derivatives as sigma-1 receptor ligands. , 2010, Journal of medicinal chemistry.

[24]  Wei Li,et al.  Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma. , 2009, Journal of medicinal chemistry.

[25]  Philippe Cuniasse,et al.  Development of Selective Inhibitors and Substrate of Matrix Metalloproteinase-12* , 2006, Journal of Biological Chemistry.

[26]  E. Stura,et al.  Strategies for Protein Cryocrystallography , 2014 .

[27]  E. Novellino,et al.  N-O-isopropyl sulfonamido-based hydroxamates: kinetic characterisation of a series of MMP-12/MMP-13 dual target inhibitors. , 2012, Biochemical pharmacology.

[28]  R. Dwek,et al.  Glycosylation and the immune system. , 2001, Science.

[29]  S. Shapiro,et al.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.

[30]  K. Yi,et al.  Di-2-Pyridyl thionocarbonate. A new reagent for the preparation of isothiocyanates and carbodiimides. , 1985 .

[31]  F. Beau,et al.  A Selective Matrix Metalloproteinase-12 Inhibitor Retards Atherosclerotic Plaque Development in Apolipoprotein E–Knockout Mice , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[32]  J. Skotnicki,et al.  Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[33]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[34]  Armando Rossello,et al.  N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity. , 2015, Journal of medicinal chemistry.

[35]  Raymond A. Dwek,et al.  Glycobiology: Toward Understanding the Function of Sugars. , 1996, Chemical reviews.

[36]  Didier Nurizzo,et al.  MxCuBE: a synchrotron beamline control environment customized for macromolecular crystallography experiments , 2010, Journal of synchrotron radiation.

[37]  N. Minoura,et al.  Chemoenzymatic synthesis of the sialyl-alpha-(2-->3')-lactosamine trisaccharide with a 3-aminopropyl group as a spacer at the reducing end. , 2003, Carbohydrate research.

[38]  H. Du,et al.  Matrix metalloproteinase 12 overexpression in lung epithelial cells plays a key role in emphysema to lung bronchioalveolar adenocarcinoma transition. , 2009, Cancer research.

[39]  V. Lagente,et al.  Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease , 2004, Inflammation Research.

[40]  M Reza Ghadiri,et al.  A heterocyclic peptide nanotube. , 2003, Journal of the American Chemical Society.

[41]  J. Kovensky,et al.  An anionic synthetic sugar containing 6‐SO3‐NAcGlc mimics the sulfated cruzipain epitope that plays a central role in immune recognition , 2012, The FEBS journal.

[42]  M. Schwartz,et al.  The Intermediate S1′ Pocket of the Endometase/Matrilysin-2 Active Site Revealed by Enzyme Inhibition Kinetic Studies, Protein Sequence Analyses, and Homology Modeling* , 2003, Journal of Biological Chemistry.

[43]  C. Luchinat,et al.  Targeting matrix metalloproteinases: design of a bifunctional inhibitor for presentation by tumour-associated galectins. , 2013, Chemistry.

[44]  N. Pannu,et al.  REFMAC5 for the refinement of macromolecular crystal structures , 2011, Acta crystallographica. Section D, Biological crystallography.

[45]  E. Stura,et al.  Screening Using Polymorphs for the Crystallization of Protein–Ligand Complexes , 2013 .

[46]  B. Ernst,et al.  Ionic-liquid-based MS probes for the chemo-enzymatic synthesis of oligosaccharides. , 2012, Organic & biomolecular chemistry.

[47]  D. D. Perrin,et al.  Purification of laboratory chemicals , 1966 .